Join Next LSI Event

Join Now

LSI Europe '24 Summit

Filling Fast

Tom Alapaattikoski - Brinter, Private Partnering Interview at LSI USA ‘23

Speakers

Tom Alapaattikoski

Tom Alapaattikoski

CEO & Co-Founder, Brinter
The company's commercial & patented 3D bioprinter and biomaterials, Brinter develops cartilaginous applications for regenerative medicine, such as meniscus, nose, ear, hip socket, and faceted joint cartilage.

Transcription

Tom Alapaattikoski  0:06  

Tom Alapaattikoski, CEO Brinter, Inc. revolutionizing healthcare with our 3d bioprinting technology and applications. With our device Brinter, we are printing bio implants like meniscus to replace ruptured meniscus and plastic pieces that are still put into people's knees every year. This is only the beginning. So with our first implants that we're heading towards clinical trials right now, we will be expanding to all the way to ears, nose, hip sockets, and other consulates products. And that's only the beginning. Because we are capable with this technology almost ready to move towards other replacement parts for humans, and eventually organs. And this device is already commercial, we sold $1 million worth of these for r&d purposes. We're right now getting our medical device classification II status, which means that these devices will be point of care and hospitals and clinics all around the world to do on site. Printing of this implant, bio implant meniscus is to a patient's needs so that we can get rid of those artificial metals and plastics and start replacing humans with biological replacement parts. We're currently preclinical, the experience that we've already had for four years that we've doing this testing of different biomaterials and developing our technology alongside with our patents, their response with our preclinical trials with animals and, etc, has been really, really good. This is our 3d bioprinting. As I mentioned before, it's fully commercial for r&d purposes. And it's super easy to use with our user interface, fully web browser compliant. How do we do it we the actual administer sprinting for our patients, we take an MRI of the patient's broken injured meniscus, that 3d model, we will upload to our user interface withdraw our user interface into our system, we fix the broken parts of the cartilage. And then we simply slice it as in 3d bioprinter. They do what we do, and then we move it to a printer. And with this device, we can immediately see the printing coming together in almost 30 minutes. Here you can see our super easy user interface. On a slicer part where you upload the meniscus implant. You can manipulate with different customization how you want to print it layer by layer using curing, and different kind of layer cell counts. You simply slice it, you examine that layers are perfectly aligned to each other to decide the curing. And you simply send the print to a printer, print job to a printer. And now by simply clicking the Start button, we can see the print job starting and after each layer. The final product will come together for this demo purpose. We're not of course using the UV light to cure the layers or you can see the full process coming together of printing a bio implant as meniscus here. We're currently growing fast. And LSI is a great place to network with strategic partnerships as well as investors as we are raising money to get this company public by 2026

 

LSI USA '24 is filling fast. Secure your spot today to join Medtech and Healthtech leaders in Dana Point.

JOIN US TODAY

Share this video

Companies We Work With